T17 cell immune polarization was discovered in patients with PAH, while intravascular triggers in CTEPH patients may stimulate CXCL9 to recruit cytotoxic lymphocytes, natural killer cells, and macrophages. The gene discussed is CXCL9; the disease is chronic thromboembolic pulmonary hypertension.